Compare SOLS & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOLS | RVTY |
|---|---|---|
| Founded | 2025 | 1937 |
| Country | United States | United States |
| Employees | 4400 | N/A |
| Industry | Aerospace | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 11.6B |
| IPO Year | N/A | 1994 |
| Metric | SOLS | RVTY |
|---|---|---|
| Price | $79.74 | $112.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $79.25 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.5M | 1.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.39% | 0.34% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | N/A | ★ $3,311,822,000.00 |
| Revenue This Year | $6.36 | $6.37 |
| Revenue Next Year | $5.64 | $5.10 |
| P/E Ratio | ★ $54.31 | $315.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $40.43 | $81.22 |
| 52 Week High | $90.80 | $118.30 |
| Indicator | SOLS | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 44.63 | 68.33 |
| Support Level | $77.29 | $95.31 |
| Resistance Level | $83.53 | $118.30 |
| Average True Range (ATR) | 4.10 | 3.88 |
| MACD | -0.37 | 1.03 |
| Stochastic Oscillator | 8.13 | 87.57 |
Solstice Advanced Materials is a diversified specialty chemicals company created in late 2025 after being spun off from Honeywell. It sells chemicals and materials to a wide range of end markets. Its largest product category is refrigerants used in heating, ventilation and air conditioning systems, and autos, where Solstice sells low global warming potential refrigerants. The company also sells materials used for building and construction, semiconductor production, healthcare packaging, and defense. Additionally, Solstice runs the only US uranium conversion business currently in operation.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.